Matrix metalloproteinase gene expression in oral lichen planus: Erosive vs. reticular forms

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 8, 2006, Pages 953-957

  Mazzarella, N ^a   Femiano, F ^a   Gombos, F ^a   De Rosa, A ^a   Giuliano, Mariateresa ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Matrix metalloproteinases; Orallichen planus; Tissue inhibitor of metalloproteinases

Indexed keywords

BETA ACTIN; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MESSENGER RNA; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; ARTICLE; BODY FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; LICHEN PLANUS; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SKIN BIOPSY;

AGED; FEMALE; GENE EXPRESSION; HUMANS; LICHEN PLANUS, ORAL; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33747352455     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01693.x     Document Type: Article

References (27)

1. Sugerman PB, Savage NW, Walsh LJ et al. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 2002; 13: 351-367.
2. de Moura Castro JC, Cardozo Pereira AL, Cabral MG et al. Oral lichen planus: Part I. Epidemiology, clinics, etiology, immunopathogeny, and diagnosis. Skinmed 2003; 2: 342-349.
3. Mollaoglu N. Oral lichen planus: A review. Br J Oral Maxillofac Surg 2000; 38: 370-377.
4. Zhou JXJ, Sugerman PB, Savage NW, Walsh LJ. Matrix metalloproteinases and their inhibitors in oral lichen planus. J Cutan Pathol 2001; 28: 72-82.
5. + T cells and basement membrane disruption in oral lichen planus. J Oral Pathol Med 2002; 31: 23-27.
6. Sugerman PB, Savage NW, Zhou X et al. Oral lichen planus. Clin Dermatol 2000; 18: 533-539.
7. Vu TH, Werb Z. Matrix metalloproteinases: Effectors of development and normal physiology. Genes Dev 2000; 14: 2123-2133.
8. Lafleur MA, Handsley MM, Edwards DR. Metalloproteinases and their inhibitors in angiogenesis. Exp Rev Mol Med 2003; 5: 1-39.
9. Rhee JS, Diaz R, Korets L et al. TIMP-1 alters susceptibility to carcinogenesis. Cancer Res 2004; 64: 952-961.
10. Scully C, Beyli M, Ferreiro MC et al. Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med 1998; 9: 86-122.
11. Rodrìguez-Nùñez I, Blanco-Carriòn A, Garcìa A, Gàndara Rey J. Peripheral T-cell subsets in patients with reticular and atrophic-erosive oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 91: 180-188.
12. Lamberti M, Perfetto B, Costabile T et al. In vitro evaluation of metalloproteinases as predictive testing for nickel, a model sensitizing agent. Toxicol Appl Pharmacol 2004; 195: 321-330.
13. Dahan M, Nawrocki B, Elkaim R et al. Expression of matrix metalloproteinases in healthy and diseased human gingiva. J Clin Periodontol 2001; 28: 128-136.
14. Konttinen YT, Ainola M, Valleala H et al. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 1999; 58: 691-697.
15. Birkedal-Hansen B, Pavelic ZP, Gluckman JL et al. MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues. Oral Dis 2000; 6: 376-382.
16. Rey JM, Pujol P, Callier P et al. Semiquantitative reverse transcription-polymerase chain reaction to evaluate the expression patterns of genes involved in the estrogen pathway. J Mol Endocrinol 2000; 24: 433-440.
17. Liu Z, Li N, Diaz LA et al. Synergy between a plasminogen cascade and MMP-9 in autoimmune disease. J Clin Invest 2005; 115: 825-828.
18. Rosenberg GA. Matrix metalloproteinase biomarkers in multiple sclerosis. Lancet 2005; 365: 1291-1293.
19. Kane D, Jensen LE, Grehan S et al. Quantitation of metalloproteinase gene expression in rheumatoid and psoriatic arthritis synovial tissue distal and proximal to the cartilage-pannus junction. J Rheumatol 2004; 31: 1274-1280.
20. Airola K, Reunala T, Salo S, Saarialho-Kere U. Urokinase plasminogen activator is expressed by basal keratinocytes before interstitial collagenase, stromelysin-1 and laminin-5 in experimentally induced dermatitis herpetiformis. J Invest Dermatol 1997; 108: 7-11.
21. Suomela S, Kariniemi AL, Impola U et al. Matrix metalloproteinase-19 is expressed by basal keratinocytes in psoriasis. Acta Derm Venereol 2003; 83: 108-114.
22. Impola U, Uitto VJ, Hietanen L et al. Differential expression of matrilysin-1 (MMP-7), 92kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol 2004; 202: 14-22.
23. Impola U, Toriseva M, Suomela S et al. Matrix metalloproteinase-19 is expressed by proliferative epithelium but disappears with neoplastic dedifferentiation. Int J Cancer 2003; 103: 709-716.
24. Karatsaidis A, Schreus O, Helgeland K et al. Erythematosus and reticular forms of oral lichen planus and oral lichenoid reactions differ in pathological features related to disease activity. J Oral Pathol Med 2003; 32: 275-281.
25. Sklavounou-Andrikopoulou A, Chrysomali E, Iakovou M et al. Elevated serum levels of the apoptosis related molecules TNF-alpha, Fas/Apo-1 and Bcl-2 in oral lichen planus. J Oral Pathol Med 2004; 33: 386-390.
26. Pasieka Z, Stepien H, Czyz W et al. Concentration of metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in the serum of patients with benign and malignant thyroid tumours treated surgically. Endocr Regul 2004; 38: 57-63.
27. Avolio C, Filippi M, Tortorella C et al. Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: Relationship with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment. Mult Scler 2005; 11: 441-446.